# Z-DNA Binding Protein 1: Structure, Function, and Role in Immunity

## Introduction to Z-DNA Binding Protein 1

Z-DNA binding protein 1 (ZBP1), also known as DAI (DNA-dependent activator of IFN-regulatory factors) or DLM-1, is a nucleic acid sensor that recognizes left-handed Z-conformation DNA and RNA. It is a critical component of the innate immune system, functioning as a pattern recognition receptor (PRR) that detects both viral and endogenous nucleic acids in the Z-conformation. ZBP1 is unique among nucleic acid sensors because it specifically recognizes the left-handed helical structure of Z-DNA and Z-RNA, rather than a specific sequence motif. This structural specificity allows ZBP1 to distinguish foreign or aberrant nucleic acids from the predominantly right-handed B-form DNA and A-form RNA that dominate cellular physiology.

### What is ZBP1?

ZBP1 is a 429-amino-acid protein in humans, encoded by the *ZBP1* gene located on chromosome 20q13.32. The protein contains two N-terminal Zα domains (Zα1 and Zα2), which are responsible for Z-nucleic acid binding, followed by two receptor-interacting protein homotypic interaction motifs (RHIMs) that mediate protein-protein interactions, and a C-terminal domain of unknown function. The Zα domains are the defining feature of the ZBP1 family and belong to the winged helix-turn-helix superfamily of DNA-binding proteins. ZBP1 is constitutively expressed at low levels in most tissues but is strongly induced by interferons and during viral infection, positioning it as an early sensor of pathogen-associated molecular patterns (PAMPs).

The protein was initially identified through three independent lines of investigation: as a tumor-associated antigen (DLM-1), as a DNA-binding protein that activates interferon expression (DAI), and as a Z-DNA binding protein (ZBP1). These discoveries converged to reveal a protein with dual roles in nucleic acid sensing and cell death regulation.

### Discovery and Naming

The history of ZBP1 nomenclature reflects its multifaceted functions. In 1999, the protein was first cloned as DLM-1 (differentially expressed in Lewis lung carcinoma) from a mouse tumor cell line, where it was found to be upregulated in metastatic cells. In 2007, the protein was independently identified as DAI (DNA-dependent activator of IFN-regulatory factors) through a functional screen for cytosolic DNA sensors that activate the type I interferon pathway. Concurrently, structural studies identified the protein as a bona fide Z-DNA binding protein, leading to the unified name ZBP1.

The gene is conserved across vertebrates, with orthologs identified in fish, birds, and mammals. Notably, the Zα domain is also found in other proteins, including ADAR1 (adenosine deaminase acting on RNA 1), PKZ (protein kinase Z), and E3L (a vaccinia virus virulence factor), indicating that Z-nucleic acid recognition is an ancient and conserved mechanism in host-pathogen interactions.

## The Zα Domain: Structural Basis for Z-DNA Recognition

The Zα domain is the archetypal Z-DNA binding module and is responsible for the high-affinity, sequence-independent recognition of left-handed Z-conformation nucleic acids. Understanding the structural basis of this interaction is essential for appreciating how ZBP1 discriminates between B-DNA and Z-DNA, a distinction that underlies its biological function.

### Zα Domain Architecture

The Zα domain is approximately 70 amino acids in length and adopts a winged helix-turn-helix (wHTH) fold. This compact structure consists of three α-helices (α1, α2, α3) and three β-strands (β1, β2, β3), arranged in a characteristic topology. The helix-turn-helix motif, formed by α2 and α3, is the primary DNA recognition element, while the β-hairpin "wing" between β2 and β3 provides additional contacts with the DNA backbone.

The domain binds to Z-DNA through the major groove, making contacts with both the sugar-phosphate backbone and the exposed edges of the bases. Unlike B-DNA, which has a deep major groove and shallow minor groove, Z-DNA has a deep minor groove and a shallow, convex major groove. The Zα domain is specifically adapted to recognize this unusual geometry, with the α3 helix fitting into the shallow major groove and the wing region interacting with the phosphate backbone on the opposite face.

The binding affinity of Zα for Z-DNA is in the nanomolar range (Kd ≈ 4 nM for the Zα domain of ZBP1), which is comparable to the affinity of many sequence-specific [transcription factors](/knowledge/molecular-biology/transcription-factor) for their cognate B-DNA sites. However, Zα binding is sequence-independent, relying instead on the conformational signature of Z-DNA. This is a critical distinction: ZBP1 does not read the genetic code but rather detects the structural state of the nucleic acid.

### Key Amino Acid Contacts

Structural studies using [X-ray crystallography](/knowledge/molecular-biology/x-ray-crystallography) have revealed the atomic details of Zα-Z-DNA interactions. The α3 helix of the Zα domain inserts into the major groove of Z-DNA, where it makes direct contacts with the C8 and N7 atoms of purines and the C5 and C6 atoms of pyrimidines. These contacts are mediated by a conserved set of amino acids, including a critical tyrosine residue (Tyr50 in human ZBP1) that stacks with the base rings, and a series of polar residues (Asn45, Arg47, and Thr53) that form hydrogen bonds with the bases and phosphate groups.

A particularly important feature is the "Zα-specific" proline residue (Pro49 in human ZBP1), which introduces a kink in the α3 helix that is essential for proper fit into the Z-DNA major groove. Mutation of this proline to alanine abolishes Z-DNA binding, demonstrating its structural importance. Additionally, the wing region contains a conserved lysine-arginine pair that contacts the phosphate backbone, contributing to the electrostatic component of binding.

The specificity for Z-DNA over B-DNA is achieved through shape complementarity and backbone contacts. The Zα domain makes extensive contacts with the zigzag phosphate backbone of Z-DNA, which has a distinctive alternating pattern of phosphate positions. In B-DNA, the phosphate backbone is more uniformly spaced, and the major groove is too deep for the α3 helix to make productive contacts. Thus, the Zα domain is a conformation-specific, not sequence-specific, DNA binding protein.

### Comparison with Other Z-DNA Binding Proteins

The Zα domain is shared among several proteins, and comparing their structures reveals both conserved features and functional specializations. The table below summarizes the key Z-DNA binding proteins and their characteristics:

| Protein | Zα Domains | Binding Affinity (Kd) | Known Functions |
|---------|------------|----------------------|-----------------|
| ZBP1 (DAI) | 2 (Zα1, Zα2) | ~4 nM (Zα1) | Innate immune sensing, necroptosis, PANoptosis |
| ADAR1 | 1 (Zα) | ~1-4 nM | RNA editing, suppression of interferon signaling |
| PKZ | 2 (Zα1, Zα2) | ~20 nM | eIF2α kinase in fish, antiviral response |
| E3L (vaccinia virus) | 1 (Zα) | ~2-10 nM | Viral virulence factor, inhibits host antiviral responses |

ADAR1 is particularly notable because its Zα domain is essential for its role in editing Z-RNA structures and preventing aberrant activation of the innate immune system. Mutations in the ADAR1 Zα domain cause Aicardi-Goutières syndrome, an autoinflammatory disease characterized by excessive type I interferon production. This highlights the importance of Z-nucleic acid recognition in maintaining immune homeostasis.

The Zα2 domain of ZBP1 is unique among these proteins. While Zα1 is the primary high-affinity Z-DNA binding domain, Zα2 has lower affinity for Z-DNA but is essential for Z-RNA binding and for the activation of downstream signaling pathways. This functional specialization suggests that the two Zα domains of ZBP1 work cooperatively to detect different forms of Z-nucleic acids.

## ZBP1 Isoforms and Expression Patterns

ZBP1 is not a single static protein but exists in multiple isoforms with distinct expression patterns and functions. Understanding this diversity is important for interpreting experimental results and for appreciating the regulatory complexity of ZBP1 biology.

### Splice Variants

The human *ZBP1* gene produces at least three alternatively spliced isoforms. The full-length isoform (ZBP1-001, 429 amino acids) contains both Zα domains, both RHIMs, and the C-terminal domain. A second isoform (ZBP1-002) lacks the C-terminal domain but retains all functional N-terminal elements. A third isoform (ZBP1-003) is truncated and lacks the second RHIM, which may affect its ability to interact with downstream signaling partners.

The functional significance of these isoforms is not fully understood, but studies suggest that they may have different subcellular localizations and signaling capacities. For example, the full-length isoform is predominantly cytoplasmic, while some truncated variants may localize to the nucleus. Additionally, the relative expression of different isoforms varies across tissues, suggesting tissue-specific regulation of splicing.

In mice, two major isoforms have been characterized: ZBP1-L (long) and ZBP1-S (short). ZBP1-S lacks a portion of the Zα2 domain and has reduced Z-RNA binding activity. The differential expression of these isoforms during development and in response to immune stimulation suggests that [alternative splicing](/blog/guides/alternative-splicing) is a regulatory mechanism that tunes ZBP1 activity.

### Inducible Expression

ZBP1 is expressed at low basal levels in most tissues, with the highest constitutive expression in the spleen, thymus, and lymph nodes. However, its expression is strongly induced by type I interferons (IFN-α and IFN-β) and by interferon-gamma (IFN-γ). This induction is mediated by interferon-stimulated response elements (ISREs) and gamma-activated sequences (GAS) in the *ZBP1* promoter.

The kinetics of ZBP1 induction are rapid: within 2-4 hours of interferon stimulation, ZBP1 mRNA levels increase 10- to 50-fold. This rapid induction positions ZBP1 as an immediate-early response gene that primes cells for subsequent nucleic acid sensing. During viral infection, ZBP1 expression is further amplified through a positive feedback loop: viral nucleic acids trigger interferon production, which upregulates ZBP1, which in turn enhances detection of viral Z-RNA.

In addition to transcriptional regulation, ZBP1 protein levels are controlled post-translationally. The protein has a short half-life (approximately 2-3 hours) and is subject to ubiquitin-mediated proteasomal degradation. Several E3 ubiquitin ligases have been implicated in ZBP1 turnover, although the specific enzymes remain incompletely characterized. This rapid turnover ensures that ZBP1 levels are tightly controlled and that inappropriate activation is minimized.

## ZBP1 in Innate Immunity: Sensing Z-RNA and Z-DNA

The primary function of ZBP1 is as a pattern recognition receptor that detects Z-conformation nucleic acids and initiates innate immune responses. This section details the molecular mechanisms by which ZBP1 recognizes its ligands and activates downstream signaling pathways.

### Recognition of Viral Z-RNA

ZBP1 was initially characterized as a DNA sensor, but subsequent studies revealed that its primary physiological ligand is Z-RNA, not Z-DNA. Z-RNA is a left-handed double-helical RNA conformation that is structurally analogous to Z-DNA but with ribose sugars and uracil instead of thymine. Z-RNA can form under specific conditions, including high salt concentrations, negative supercoiling, and certain base modifications.

During viral infection, Z-RNA is produced as a replication intermediate. Influenza A virus (IAV) is the best-studied example: the viral nucleoprotein and RNA-dependent RNA polymerase generate double-stranded RNA replication intermediates that adopt the Z-conformation. These Z-RNAs are recognized by the Zα2 domain of ZBP1 with high specificity. The binding of Z-RNA to ZBP1 induces a conformational change that exposes the RHIM domains, allowing them to interact with downstream signaling proteins.

Importantly, ZBP1 does not recognize all viral RNAs indiscriminately. The Z-conformation is a rare and energetically unfavorable state for RNA, and its formation requires specific sequence and structural contexts. The most well-characterized Z-RNA sequences are those with alternating purine-pyrimidine repeats, particularly (CG)n motifs, which have the lowest energy barrier for Z-conformation adoption. During IAV infection, the viral genome contains such motifs, enabling ZBP1 to specifically detect viral replication without responding to host RNAs.

### Activation of NF-κB and IRF3

Upon Z-RNA binding, ZBP1 activates two major [transcription factor](/knowledge/molecular-biology/transcription-factor) pathways: NF-κB and IRF3. These pathways coordinately induce the expression of type I interferons, pro-inflammatory cytokines, and chemokines.

The NF-κB pathway is activated through a signaling cascade that begins with the recruitment of the kinase RIPK1 (receptor-interacting protein kinase 1) to the ZBP1 RHIM domains. RIPK1 then activates the IKK complex (IκB kinase), which phosphorylates IκBα, targeting it for ubiquitin-mediated degradation. The release of NF-κB from IκBα inhibition allows NF-κB to translocate to the nucleus and drive transcription of target genes, including *IFNB1* (interferon-beta), *TNF* (tumor necrosis factor), and *IL6* (interleukin-6).

The IRF3 pathway is activated through a parallel mechanism involving the kinase TBK1 (TANK-binding kinase 1). ZBP1 recruits TBK1 through an interaction that is facilitated by the adaptor protein TANK. TBK1 phosphorylates IRF3 at Ser385 and Ser386, promoting IRF3 dimerization and nuclear translocation. In the nucleus, IRF3 cooperates with NF-κB and AP-1 to form the enhanceosome complex at the *IFNB1* promoter, driving robust interferon-beta production.

The activation of both NF-κB and IRF3 by ZBP1 is dependent on the RHIM domains, as mutations that disrupt RHIM function abolish downstream signaling. This indicates that ZBP1 functions as a scaffold that nucleates the assembly of a signaling complex, rather than as a kinase or enzyme itself.

### Role in Necroptosis and PANoptosis

In addition to activating inflammatory gene expression, ZBP1 is a potent inducer of programmed cell death. The cell death pathways activated by ZBP1 are distinct from apoptosis and include necroptosis and pyroptosis. The term "PANoptosis" has been coined to describe the coordinated activation of multiple cell death pathways by a single trigger, and ZBP1 is a central mediator of this process.

Necroptosis is a form of regulated necrosis that requires the kinase activity of RIPK3 and the pseudokinase MLKL (mixed lineage kinase domain-like protein). ZBP1 activates necroptosis by recruiting RIPK3 through RHIM-RHIM interactions. RIPK3 then phosphorylates MLKL, which oligomerizes and translocates to the plasma membrane, where it forms pores that disrupt membrane integrity and cause cell lysis.

Pyroptosis is a lytic form of cell death mediated by gasdermin proteins, particularly gasdermin D (GSDMD). ZBP1 can activate pyroptosis through the inflammasome pathway, which involves the activation of caspase-1 and the cleavage of GSDMD. The N-terminal fragment of GSDMD forms membrane pores, leading to cell swelling and lysis.

The simultaneous activation of necroptosis and pyroptosis by ZBP1 is a hallmark of PANoptosis. This coordinated cell death response is particularly important for antiviral defense, as it eliminates infected cells through multiple redundant mechanisms, reducing the likelihood that viruses can evade cell death through inhibition of a single pathway.

## ZBP1 in Inflammation and Cell Death

The role of ZBP1 in cell death extends beyond antiviral defense and has significant implications for inflammatory diseases. Understanding the molecular mechanisms of ZBP1-mediated cell death is essential for appreciating its pathophysiological roles.

### Interaction with RIPK3

The interaction between ZBP1 and RIPK3 is the central event in ZBP1-mediated necroptosis. This interaction is mediated by the RHIM domains of both proteins. RHIMs are approximately 19-amino-acid motifs that mediate homotypic and heterotypic protein-protein interactions through the formation of amyloid-like fibrils.

The ZBP1-RIPK3 interaction is regulated by RIPK1, which can either promote or inhibit necroptosis depending on the context. In unstimulated cells, RIPK1 binds to RIPK3 and prevents its activation. However, when ZBP1 is activated by Z-RNA binding, it competes with RIPK1 for RIPK3 binding, displacing RIPK1 and allowing RIPK3 to autophosphorylate and become active. This "RIPK1-to-RIPK3 switch" is a critical regulatory checkpoint in necroptosis signaling.

The kinase activity of RIPK3 is essential for necroptosis. RIPK3 autophosphorylation at Ser227 (in humans) stabilizes its active conformation and promotes the recruitment and phosphorylation of MLKL. MLKL phosphorylation at Thr357 and Ser358 triggers its oligomerization and membrane translocation. The oligomerized MLKL forms cation-permeable pores in the plasma membrane, leading to osmotic lysis and the release of damage-associated molecular patterns (DAMPs) that amplify inflammation.

### ZBP1-Mediated Necroptosis

ZBP1-mediated necroptosis can be triggered by both viral and endogenous Z-RNAs. During IAV infection, ZBP1 detects viral Z-RNA and initiates necroptosis through the RIPK3-MLKL pathway. This is a major antiviral mechanism, as mice lacking ZBP1 are highly susceptible to IAV infection and show reduced survival compared to wild-type mice.

In addition to viral triggers, ZBP1 can mediate necroptosis in response to endogenous Z-RNAs that accumulate under conditions of cellular stress. For example, during embryonic development, ZBP1 is required for the programmed necroptosis of cells in the interdigital webs of the developing limb. This developmental role of ZBP1 demonstrates that it is not solely a pathogen sensor but also functions in normal physiological processes.

The regulation of ZBP1-mediated necroptosis is complex and involves multiple checkpoints. The E3 ubiquitin ligase Peli1 has been shown to ubiquitinate ZBP1 and promote its activation, while the deubiquitinase CYLD removes ubiquitin chains and inhibits ZBP1 signaling. Additionally, the kinase TBK1 can phosphorylate ZBP1 and inhibit its cell death activity, providing a negative feedback mechanism that limits excessive cell death.

### ZBP1 in PANoptosis

PANoptosis is a recently defined concept that describes the coordinated activation of pyroptosis, apoptosis, and necroptosis in response to a single trigger. ZBP1 is a key mediator of PANoptosis, particularly in the context of IAV infection.

The ZBP1-mediated PANoptosis pathway involves the formation of a multiprotein complex called the PANoptosome. The PANoptosome contains ZBP1, RIPK3, RIPK1, caspase-8, ASC (apoptosis-associated speck-like protein containing a CARD), and NLRP3. The assembly of this complex allows for the simultaneous activation of multiple cell death pathways: caspase-8 activation leads to apoptosis, RIPK3-MLKL activation leads to necroptosis, and NLRP3-ASC-caspase-1 activation leads to pyroptosis.

The biological significance of PANoptosis is that it provides redundancy in cell death execution. If a virus inhibits one cell death pathway, the other pathways can still eliminate the infected cell. This is particularly important for viruses like IAV that encode inhibitors of apoptosis, as PANoptosis ensures that cell death still occurs through necroptosis and pyroptosis.

## ZBP1 in Viral Infection and Antiviral Defense

ZBP1 plays a critical role in defense against multiple viruses, with the most detailed studies conducted on influenza A virus, vaccinia virus, and herpes simplex virus. The mechanisms of ZBP1-mediated antiviral defense vary among these viruses, reflecting differences in their replication strategies and Z-RNA production.

### Influenza A Virus

Influenza A virus is the best-characterized viral trigger of ZBP1. During IAV infection, the viral RNA-dependent RNA polymerase synthesizes double-stranded RNA replication intermediates that adopt the Z-conformation. These Z-RNAs are recognized by ZBP1, leading to the activation of both inflammatory signaling and cell death pathways.

The Z-RNA produced during IAV infection is derived from the viral genome, which contains specific sequences that favor Z-conformation adoption. The 5' and 3' untranslated regions of IAV segments contain [conserved sequences](/knowledge/molecular-biology/conserved-sequence) with alternating purine-pyrimidine motifs that can form Z-RNA. Additionally, the viral nucleoprotein (NP) has been shown to promote Z-RNA formation by stabilizing the Z-conformation of viral RNA.

ZBP1-deficient mice are highly susceptible to IAV infection, showing increased viral titers, more severe lung pathology, and reduced survival. The antiviral function of ZBP1 is mediated through both interferon-dependent and interferon-independent mechanisms. The interferon-dependent mechanism involves the activation of NF-κB and IRF3, leading to type I interferon production and the establishment of an antiviral state. The interferon-independent mechanism involves the direct induction of necroptosis and PANoptosis in infected cells, limiting viral replication by eliminating the cellular machinery required for viral propagation.

### Vaccinia Virus

Vaccinia virus (VACV), the vaccine strain used for smallpox eradication, encodes the E3L protein, which contains a Zα domain. E3L is a virulence factor that inhibits host antiviral responses, and its Zα domain is essential for this function. The mechanism by which E3L inhibits ZBP1 is through competition for Z-RNA binding: E3L binds to Z-RNAs with high affinity, sequestering them and preventing their recognition by ZBP1.

The importance of the E3L Zα domain for viral virulence is demonstrated by studies showing that VACV mutants lacking the Zα domain are attenuated and induce stronger innate immune responses. These mutants are recognized by ZBP1, leading to enhanced interferon production and cell death. This competition between viral and host Zα domains represents a molecular arms race in which both the virus and the host have evolved Z-nucleic acid binding proteins to either evade or activate innate immunity.

Interestingly, the Zα domain of E3L is also required for viral replication in cells that express ZBP1, suggesting that E3L must actively suppress ZBP1 function to allow viral replication. In cells lacking ZBP1, the Zα domain of E3L is dispensable for viral replication, confirming that the primary function of the E3L Zα domain is to counteract ZBP1.

### Herpes Simplex Virus

Herpes simplex virus 1 (HSV-1) is a DNA virus that does not produce RNA replication intermediates in the same manner as RNA viruses. However, HSV-1 infection still activates ZBP1, suggesting that ZBP1 can also detect Z-DNA or Z-RNA produced during DNA virus replication.

The mechanism of ZBP1 activation during HSV-1 infection is less well understood than for IAV. It is possible that the viral DNA itself adopts the Z-conformation in certain regions, or that viral transcripts form Z-RNA structures. Additionally, HSV-1 infection induces cellular stress responses that may promote the formation of endogenous Z-RNAs, which could then be detected by ZBP1.

Studies have shown that ZBP1 contributes to the antiviral response against HSV-1, but its role is less critical than for IAV. ZBP1-deficient mice show increased susceptibility to HSV-1 infection, but the effect is modest compared to IAV. This suggests that ZBP1 is one of multiple redundant sensors that detect HSV-1, and that other pathways can partially compensate for ZBP1 loss.

## Methods to Study ZBP1 and Z-DNA Binding

Investigating ZBP1 function requires a combination of biochemical, structural, and cellular approaches. This section provides an overview of the most commonly used techniques, with practical details for each method.

### Electrophoretic Mobility Shift Assay (EMSA)

The electrophoretic mobility shift assay (EMSA) is the standard method for measuring ZBP1 binding to Z-DNA or Z-RNA. In this assay, a radiolabeled or fluorescently labeled nucleic acid probe is incubated with purified ZBP1 protein, and the mixture is resolved on a native polyacrylamide gel. Protein-bound DNA migrates more slowly than free DNA, resulting in a shifted band.

For Z-DNA binding assays, the probe is typically a double-stranded oligonucleotide with a sequence that favors Z-conformation, such as (CG)₆ or (CA)₆. The Z-conformation is stabilized by including 1-2 mM spermidine or by using a buffer with high salt concentration (100-200 mM NaCl). The binding reaction is typically performed in 20 mM HEPES (pH 7.5), 50 mM KCl, 1 mM DTT, 5% glycerol, and 0.1 mg/mL bovine serum albumin, incubated at room temperature for 30 minutes.

The dissociation constant (Kd) can be determined by performing EMSA with increasing concentrations of protein and quantifying the fraction of bound probe. For ZBP1 Zα domains, the Kd is typically in the low nanomolar range (1-10 nM). Competition assays can be performed by adding unlabeled competitor DNA in B- or Z-conformation to confirm specificity.

### X-ray Crystallography

X-ray crystallography has been instrumental in determining the three-dimensional structures of ZBP1 Zα domains in complex with Z-DNA. The Zα domain of ZBP1 was one of the first Z-DNA binding domains to be crystallized, and its structure provided the first atomic-level view of Z-DNA recognition.

For crystallization, the Zα domain is typically expressed in *E. coli* as a GST (glutathione S-transferase) fusion protein and purified by [His Tag Protein Purification](/knowledge/molecular-biology/his-tag-protein-purification) followed by GST affinity chromatography and size-exclusion chromatography. The purified protein is concentrated to 10-20 mg/mL and mixed with a Z-DNA oligonucleotide (typically 6-8 base pairs) at a 1:1 molar ratio. Crystals are grown by vapor diffusion at 18-20°C using a reservoir solution containing 20-30% PEG 3350, 0.2 M ammonium acetate, and 0.1 M MES (pH 6.5).

Diffraction data are collected at synchrotron sources, and the structure is solved by molecular replacement using the ADAR1 Zα domain structure as a search model. The resulting structures reveal the detailed contacts between the Zα domain and Z-DNA, providing insights into the molecular basis of conformational specificity.

### Circular Dichroism Spectroscopy

Circular dichroism (CD) spectroscopy is a powerful technique for monitoring the B-to-Z transition of DNA and for confirming that a nucleic acid probe is in the Z-conformation. CD spectra of B-DNA and Z-DNA are markedly different: B-DNA has a positive band at approximately 275 nm and a negative band at approximately 245 nm, while Z-DNA has a negative band at approximately 290 nm and a positive band at approximately 260 nm (inverted spectrum).

To study ZBP1-induced B-to-Z transition, a B-DNA oligonucleotide is incubated with ZBP1 protein, and CD spectra are recorded over time. The appearance of the characteristic Z-DNA CD signature indicates that ZBP1 has induced the conformational transition. This assay is particularly useful for studying the kinetics of Z-DNA induction and for comparing the activities of different ZBP1 mutants.

CD spectroscopy can also be used to verify that RNA probes adopt the Z-conformation. Z-RNA has a CD spectrum similar to Z-DNA but with slight shifts in peak positions due to the presence of ribose sugars and uracil.

### Cellular Knockout Models

Genetic knockout models are essential for studying ZBP1 function in vivo. ZBP1 knockout mice have been generated and are viable and fertile, with no obvious developmental defects under specific-pathogen-free conditions. However, these mice show increased susceptibility to IAV infection and reduced inflammatory responses.

Cellular knockout models are generated using CRISPR-Cas9 technology. For example, ZBP1 knockout in immortalized mouse embryonic fibroblasts (MEFs) or in the human monocytic cell line THP-1 allows for detailed mechanistic studies. These cells can be used to assess ZBP1-dependent signaling by measuring interferon production, cytokine secretion, and cell death in response to Z-RNA stimulation or viral infection.

A common approach is to reconstitute ZBP1 knockout cells with wild-type or mutant ZBP1 constructs to identify the domains required for specific functions. For example, cells expressing ZBP1 with mutated RHIM domains can be used to determine whether RHIM-mediated interactions are required for necroptosis but not for interferon induction.

## ZBP1 in Disease: Cancer and Autoimmunity

Beyond its role in infectious disease, ZBP1 has emerged as a player in cancer and autoimmune conditions. The dual nature of ZBP1—as both a tumor suppressor and a potential tumor promoter—reflects the context-dependent effects of inflammation and cell death.

### Tumor Suppressor or Promoter?

The role of ZBP1 in cancer is complex and context-dependent. On one hand, ZBP1 can function as a tumor suppressor by promoting immunogenic cell death and activating antitumor immune responses. Necroptosis and pyroptosis are highly immunogenic forms of cell death that release DAMPs, which activate dendritic cells and promote T cell responses against tumor antigens. ZBP1-mediated cell death in tumor cells can therefore enhance antitumor immunity.

Several studies have shown that ZBP1 expression is reduced in certain cancers, including colorectal cancer and hepatocellular carcinoma, suggesting that loss of ZBP1 may contribute to tumor progression. In these contexts, ZBP1 may act as a tumor suppressor by eliminating transformed cells through programmed cell death.

On the other hand, ZBP1 can promote tumor progression under certain conditions. [Chronic inflammation](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/chronic-inflammation-causes-and-morphologic-features) driven by ZBP1 activation can create a tumor-promoting microenvironment characterized by the presence of immunosuppressive cells, such as myeloid-derived suppressor cells (MDSCs) and regulatory T cells. Additionally, ZBP1-mediated necroptosis in the tumor microenvironment can release factors that promote angiogenesis and metastasis.

The dual role of ZBP1 in cancer is reminiscent of the dual role of inflammation in tumorigenesis: acute inflammation can be protective, while chronic inflammation can be detrimental. The outcome of ZBP1 activation in cancer likely depends on the balance between immunogenic cell death and chronic inflammatory signaling.

### ZBP1 and Lupus

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of antibodies against self-nucleic acids and the activation of type I interferon pathways. ZBP1 has been implicated in SLE pathogenesis through its role in sensing endogenous Z-nucleic acids.

In SLE patients, elevated levels of Z-DNA and Z-RNA have been detected in the serum and in immune complexes. These Z-nucleic acids can activate ZBP1 in plasmacytoid dendritic cells, leading to type I interferon production and the amplification of autoimmune responses. Additionally, ZBP1-mediated cell death can release more Z-nucleic acids, creating a positive feedback loop that perpetuates inflammation.

Genetic studies have identified polymorphisms in the *ZBP1* gene that are associated with SLE susceptibility. One such polymorphism, rs2071430, is located in the promoter region and affects ZBP1 expression levels. Individuals carrying the risk allele have higher ZBP1 expression, which may predispose them to excessive interferon production and autoimmunity.

The connection between ZBP1 and SLE is further supported by studies of ADAR1, which shares the Zα domain with ZBP1. Mutations in ADAR1 cause Aicardi-Goutières syndrome, a monogenic disorder that phenotypically overlaps with SLE. This suggests that dysregulation of Z-nucleic acid sensing, whether through ZBP1 or ADAR1, can trigger autoimmune pathology.

## Common Pitfalls and Practical Summary

Studying ZBP1 presents several challenges, and there are common misconceptions that can lead to [experimental errors](/blog/guides/experimental-errors-types-sources-and-how-to-minimize-them) or misinterpretation of data. This section highlights the most frequent pitfalls and provides practical guidance for avoiding them.

### Misconception: ZBP1 Only Binds DNA

A common misconception is that ZBP1 is exclusively a DNA-binding protein. While ZBP1 was initially identified as a DNA sensor, extensive research has shown that its primary physiological ligand is Z-RNA, not Z-DNA. The Zα2 domain of ZBP1 has higher affinity for Z-RNA than for Z-DNA, and Z-RNA is the trigger for ZBP1-mediated cell death during viral infection.

This misconception can lead to experimental errors, such as using only DNA probes in binding assays or assuming that ZBP1 activation in cells is due to DNA sensing. When designing experiments, it is important to test both Z-DNA and Z-RNA substrates and to consider that the relative affinity for each ligand may differ between the Zα1 and Zα2 domains.

### Importance of Z-RNA

Related to the above, the importance of Z-RNA in ZBP1 biology is often underestimated. Z-RNA is not merely a laboratory curiosity but is a physiologically relevant ligand that is produced during viral replication and under conditions of cellular stress. The Z-conformation of RNA is stabilized by specific sequence motifs, particularly alternating purine-pyrimidine sequences, and by negative supercoiling.

When studying ZBP1, it is essential to use appropriate RNA substrates. RNA oligonucleotides should be synthesized with 2'-O-methyl modifications to resist nuclease degradation, and the Z-conformation should be verified by CD spectroscopy before use in binding assays. Additionally, care should be taken to avoid RNA degradation, as fragmented RNA may not adopt the Z-conformation.

### Key Points for Exams

For students preparing for exams, the following points are essential:

1. ZBP1 is a pattern recognition receptor that specifically recognizes left-handed Z-conformation nucleic acids (Z-DNA and Z-RNA).
2. The Zα domain is the nucleic acid binding module and adopts a winged helix-turn-helix fold.
3. ZBP1 contains two Zα domains (Zα1 and Zα2) and two RHIM domains.
4. ZBP1 activates NF-κB and IRF3 pathways, leading to type I interferon production.
5. ZBP1 induces necroptosis through RIPK3-MLKL signaling and participates in PANoptosis.
6. Influenza A virus produces Z-RNA that is recognized by ZBP1, making ZBP1 essential for antiviral defense.
7. ZBP1 is regulated by interferons and is involved in both infectious and autoimmune diseases.

## Frequently Asked Questions

### What is Z-DNA binding protein 1?

Z-DNA binding protein 1 (ZBP1), also known as DAI or DLM-1, is an innate immune sensor that specifically recognizes left-handed Z-conformation nucleic acids (Z-DNA and Z-RNA). It is a 429-amino-acid protein in humans that contains two N-terminal Zα domains for nucleic acid binding and two C-terminal RHIM domains for protein-protein interactions. ZBP1 is induced by interferons and plays critical roles in antiviral defense, inflammation, and programmed cell death.

### What does ZBP1 do?

ZBP1 functions as a pattern recognition receptor that detects Z-RNA and Z-DNA produced during viral infection or cellular stress. Upon ligand binding, ZBP1 activates two major signaling pathways: the NF-κB and IRF3 pathways, which induce type I interferon and pro-inflammatory cytokine expression, and the RIPK3-MLKL pathway, which triggers necroptosis. ZBP1 also participates in PANoptosis, a coordinated form of cell death involving pyroptosis, apoptosis, and necroptosis.

### What is the Zα domain?

The Zα domain is a approximately 70-amino-acid protein module that specifically binds to left-handed Z-conformation nucleic acids. It adopts a winged helix-turn-helix fold and makes sequence-independent contacts with the Z-DNA or Z-RNA backbone and bases. The Zα domain is found in several proteins, including ZBP1 (which has two copies), ADAR1, PKZ, and the vaccinia virus E3L protein. The binding affinity of Zα domains for Z-DNA is typically in the nanomolar range.

### How does ZBP1 induce necroptosis?

ZBP1 induces necroptosis by recruiting RIPK3 through RHIM-RHIM interactions. Upon Z-RNA binding, ZBP1 undergoes a conformational change that exposes its RHIM domains, allowing them to interact with the RHIM of RIPK3. This interaction promotes RIPK3 autophosphorylation and activation. Activated RIPK3 then phosphorylates MLKL, which oligomerizes and translocates to the plasma membrane, where it forms pores that disrupt membrane integrity and cause cell lysis.

### What is the difference between Z-DNA and B-DNA?

B-DNA is the standard right-handed double helix described by Watson and Crick, with a diameter of approximately 20 Å, a helical repeat of 10.5 base pairs per turn, and a deep major groove and shallow minor groove. Z-DNA is a left-handed double helix with a diameter of approximately 18 Å, a helical repeat of 12 base pairs per turn, and a zigzag phosphate backbone. Z-DNA has a deep minor groove and a shallow, convex major groove. The B-to-Z transition is favored by alternating purine-pyrimidine sequences, high salt concentrations, and negative supercoiling.

### Is ZBP1 involved in cancer?

Yes, ZBP1 has been implicated in cancer, but its role is context-dependent. ZBP1 can act as a tumor suppressor by promoting immunogenic cell death (necroptosis and pyroptosis) that activates antitumor immune responses. However, chronic ZBP1 activation can also promote tumor progression by creating an inflammatory microenvironment that supports tumor growth. ZBP1 expression is reduced in some cancers, suggesting that its loss may contribute to tumor development.

### How is ZBP1 studied in the lab?

ZBP1 is studied using a combination of biochemical, structural, and cellular approaches. Common methods include electrophoretic mobility shift assays (EMSA) to measure Z-DNA/Z-RNA binding, X-ray crystallography to determine the structure of Zα domains in complex with Z-DNA, circular dichroism spectroscopy to monitor the B-to-Z transition, and CRISPR-Cas9 knockout models to study ZBP1 function in cells and mice. Reporter assays measuring interferon promoter activation and cell death assays are also widely used.

## Key Takeaways

- ZBP1 is a conformation-specific nucleic acid sensor that recognizes left-handed Z-DNA and Z-RNA, not specific sequences.
- The Zα domain is the defining structural feature of ZBP1 and is shared with other proteins including ADAR1 and viral E3L.
- ZBP1 activates both inflammatory signaling (NF-κB, IRF3) and programmed cell death (necroptosis, PANoptosis) in response to Z-RNA.
- Influenza A virus is the best-characterized viral trigger of ZBP1, and ZBP1 is essential for antiviral defense against IAV.
- ZBP1 expression is induced by interferons, creating a positive feedback loop that amplifies innate immune responses.
- ZBP1 has dual roles in disease, functioning as a tumor suppressor in some contexts and promoting inflammation in others.
- The distinction between Z-DNA and B-DNA is structural, not sequence-based, and Z-RNA is the primary physiological ligand for ZBP1.

## Further Reading

- Song Q et al. *Z-DNA binding protein 1 orchestrates innate immunity and inflammatory cell death*. Cytokine & growth factor reviews. 2024. [PubMed 38548490](https://doi.org/10.1016/j.cytogfr.2024.03.005)
- Huang Y et al. *Z-DNA-binding protein 1-mediated programmed cell death: Mechanisms and therapeutic implications*. Chinese medical journal. 2025. [PubMed 40851365](https://doi.org/10.1097/CM9.0000000000003737)
- Yuan F et al. *Z-DNA binding protein 1 promotes heatstroke-induced cell death*. Science (New York, N.Y.). 2022. [PubMed 35511979](https://doi.org/10.1126/science.abg5251)
- Zhang X et al. *Z-DNA-binding protein 1 exacerbates myocardial ischemia‒reperfusion injury by inducing noncanonical cardiomyocyte PANoptosis*. [Signal transduction](/knowledge/molecular-biology/signal-transduction) and targeted therapy. 2025. [PubMed 41052986](https://doi.org/10.1038/s41392-025-02430-5)
- Chen C et al. *Role of Z-DNA Binding Protein 1 Sensing Mitochondrial Z-DNA and Triggering Necroptosis in Oxalate-Induced Acute Kidney Injury*. Journal of the American Society of Nephrology : JASN. 2025. [PubMed 39374087](https://doi.org/10.1681/ASN.0000000516)
- Li F et al. *Heat stress activates the coagulation cascade through Z-DNA-binding protein 1-dependent necroptosis*. Blood. 2026. [PubMed 41481380](https://doi.org/10.1182/blood.2025030764)

## Related Topics

- [B vs Z DNA](/knowledge/molecular-biology/b-vs-z-dna)
- [Z DNA Form](/knowledge/molecular-biology/z-dna-form)
- [Z DNA Found](/knowledge/molecular-biology/z-dna-found)
- [Z DNA Characteristics](/knowledge/molecular-biology/z-dna-characteristics)
- [Z DNA Alebo Zo DNA](/knowledge/molecular-biology/z-dna-alebo-zo-dna)

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)